| 前收市價 | 2.4500 |
| 開市 | 2.4200 |
| 買盤 | 0.0000 x 0 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 2.4000 - 2.5454 |
| 52 週波幅 | 1.8100 - 3.5700 |
| 成交量 | |
| 平均成交量 | 9,467 |
| 市值 | 205.775M |
| Beta 值 (5 年，每月) | 0.67 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.1000 |
| 業績公佈日 | 2024年5月10日 - 2024年5月18日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.41 |
ZacksAll You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy
Innate Pharma (IPHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insider MonkeyInnate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial […]
Insider MonkeyInnate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Thank you for standing by, and welcome to the Innate Pharma Third Quarter 2023 Financial Results and Business Update. I would now like to welcome Henry Wheeler, VP, Investor Relations and Communications, to begin the call. Henry, over to you. Henry Wheeler: […]
